Vicarious Surgical exec disposes 817 shares in mandatory 'sell to cover' trade
Rhea-AI Filing Summary
Adam David Sachs, President and Director of Vicarious Surgical Inc. (RBOT), sold 817 shares of Class A common stock on 08/20/2025 to satisfy tax withholding on vested restricted stock units. The sales were executed as a mandatory "sell to cover" under the company's equity plan and are not discretionary trades. The weighted average sale price was $6.0312 per share, with individual trade prices ranging from $5.90 to $6.32. After the transaction Sachs beneficially owned 49,627 shares. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Positive
- Clear disclosure of transaction date, number of shares sold, and weighted average price
- Sale labeled non-discretionary and tied to RSU tax withholding, which increases transparency
- Reporting person identified with roles (President, Director, 10% owner) aiding investor context
- Issuer offers to provide per-trade details on request, enhancing transparency
Negative
- None.
Insights
TL;DR: Insignificant insider sale to cover taxes; small position change unlikely to affect valuation.
The filing documents a routine, non-discretionary sale of 817 shares to satisfy tax-withholding on vested RSUs. The trade was executed under the issuer's mandatory "sell to cover" election, indicating this was an administrative transaction rather than a purposeful liquidity event. The weighted average price of $6.0312 and the stated price range provide transparency on execution. The remaining beneficial ownership of 49,627 shares should be assessed relative to total float for materiality, but the filing itself shows a minor reduction in holdings.
TL;DR: Disclosure aligns with Section 16 requirements; the explanation clarifies the non-discretionary nature of the sale.
The Form 4 clearly identifies the reporting person as a President, Director and 10% owner and includes an explicit explanation that the sale was to cover tax withholding on RSU vesting. The attestation by an attorney-in-fact and the offer to provide per-trade sale details support compliance and transparency. No governance red flags are apparent from the document; the transaction is consistent with the company's equity plan mechanics.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 817 | $6.0312 | $5K |
Footnotes (1)
- The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $5.90 to $6.32 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.
